Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1.
Stefania MitolaCosetta RavelliMichela CorsiniAlessandra GianoncelliFederico GalvagniKurt Ballmer-HoferMarco PrestaElisabetta GrilloPublished in: International journal of molecular sciences (2022)
Gremlin-1 is a secreted cystine-knot protein that acts as an antagonist of bone morphogenetic proteins (BMPs), and as a ligand of heparin and the vascular endothelial growth factor receptor 2 (VEGFR2), thus regulating several physiological and pathological processes, including embryonic development, tissue fibrosis and cancer. Gremlin-1 exerts all these biological activities only in its homodimeric form. Here, we propose a multi-step approach for the expression and purification of homodimeric, fully active, histidine-tagged recombinant gremlin-1, using mammalian HEK293T cells. Ion metal affinity chromatography (IMAC) of crude supernatant followed by heparin-affinity chromatography enables obtaining a highly pure recombinant dimeric gremlin-1 protein, exhibiting both BMP antagonist and potent VEGFR2 agonist activities.
Keyphrases
- vascular endothelial growth factor
- cell free
- mass spectrometry
- binding protein
- high speed
- endothelial cells
- venous thromboembolism
- poor prognosis
- tandem mass spectrometry
- liquid chromatography
- high performance liquid chromatography
- growth factor
- papillary thyroid
- mesenchymal stem cells
- amino acid
- squamous cell
- squamous cell carcinoma
- soft tissue
- high resolution
- young adults
- body composition
- bone marrow
- long non coding rna
- lymph node metastasis